G: Therapeutic and Translational Immunology*
G: Therapeutic and Translational Immunology*
April 19, 2026 08:00 11:15 253
Sunday, April 19, 2026
8:00–11:15 AM
Room 253
MAJOR SYMPOSIUM G
Therapeutic and Translational Immunology*
Chairs:
Jane Grogan, Biogen, USA
Jamie Spangler, Johns Hopkins Univ., USA
Speakers:
Donna Flesher, Biogen, USA, From signal to strategy: Integrating biomarkers in clinical trials to accelerate drug development in transplant
Sai Reddy, ETH Zurich, DEU, Generative design of antibody Fc variants with synthetic and programmable immune function
Faez Amokrane Nait Mohamed, Harvard Med. Sch., USA, Intranasal administration of a pan-reactive influenza antibody reveals Fc-independent mode of protection
Jamie Spangler, Johns Hopkins Univ., USA, Engineering cytokine/antibody fusion proteins as targeted immunotherapeutics
James Torchia, Dana-Farber Cancer Inst., Harvard Med. Sch., USA, Targeted immunosuppression with a tissue-selective PD-1 agonist prevents rejection of transplanted hearts
John E. Harris, UMass Med. Sch., USA, Vitiligo treatment from the Bronze Age to the Age of Biologics: new hope for an ancient disease
Michael Birnbaum, MIT, USA, Decoding adaptive immunity
*topic requested by IMMUNOLOGY2025™ attendees